Skip to main content
. 2023 Mar 31;46:101171. doi: 10.1016/j.gore.2023.101171

Table 2.

Germline and somatic tumor testing.

Patient Germline Somatic Testing
MSI TMB (Muts/Mb) LOH PDL1 Somatic gene mutations
1 Negative Stable 0 3.30% <1% ARID1A, PPP2R1A
2 Negative Stable 3.7 NA <1% TP53, NCOR1, MCL1
3 Negative Stable 4 <16% NA PIK3CA, ARID1A, TERT



MSI = microsatellite instability; TMB = tumor mutational burden; LOH = loss of heterozygosity; NA = not performed